" /> Dystonia, dopa-responsive, due to sepiapterin reductase deficiency - CISMeF





Preferred Label : Dystonia, dopa-responsive, due to sepiapterin reductase deficiency;

CISMeF acronym : SRD;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Sepiapterin reductase deficiency; SRD; Spr deficiency;

Description : SPR deficiency results in neurologic deterioration due to severe dopamine and serotonin deficiencies in the central nervous system caused by a defect in BH4 synthesis. Clinically, affected individuals show an L-DOPA-responsive, diurnally fluctuating movement disorder usually associated with cognitive delay and severe neurologic dysfunction. BH4 is a required cofactor for the synthesis of the neurotransmitters dopamine and serotonin. BH4 is also a required cofactor for phenylalanine hydroxylase (PAH; 612349), but patients with SPR deficiency do not exhibit overt hyperphenylalaninemia. The lack of hyperphenylalaninemia distinguishes SPR deficiency from other disorders of BH4 synthesis (see, e.g., HPABH4A, 261640). However, the neurologic phenotype of SPR deficiency resembles the other BH4-deficient disorders (summary by Bonafe et al., 2001 and Friedman et al., 2012). Another form of dopa-responsive dystonia (DTY5; 128230) is caused by mutation in the gene encoding GTP cyclohydrolase I (GCH1; 600225), which is also a component of the biopterin synthetic pathway.;

Inheritance : Autosomal recessive; ?Autosomal dominant;

Molecular basis : Caused by mutation in the sepiapterin reductase gene (SPR, 182125.0001);

Laboratory abnormalities : Sepiapterin reductase deficiency (fibroblasts); Decreased homovanillic acid (HVA) in CSF; Elevated dihydrobiopterin in CSF; Decreased 5-hydroxyindoleacetic acid (5-HIAA) in CSF; Elevated biopterin in CSF; Elevated sepiapterin in CSF; Decreased urinary HVA, 5-HIAA, and vanillyl mandelic acid (VMA); Normal urinary pterins; No hyperphenylalaninemia; Transient hyperphenylalaninemia occurs on oral loading test with phenylalanine;

Prefixed ID : #612716;

Details


You can consult :


Nous contacter.
18/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.